2026, 3-4, Anno, Autore, Cancanelli, Confronti Indiretti di Efficacia, Damuzzo, Del Bono, Gasperoni, Gori, Impact factor, Inno, Ossato, Pubblicazioni, Sava, Tessari, Topic, Vecchia
Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparison
1-2, 2026, Analisi statistiche e metanalisi, Anno, Autore, Brunoro, Impact factor, Messori, Paoli, Pubblicazioni, Rivano, Topic
Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials
1-2, 2026, Analisi statistiche e metanalisi, Anno, Autore, Brunoro, Cesca, Dispositivi medici, Impact factor, Messori, Ossato, Pubblicazioni, Rivano, Topic